IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Current Value
$163.751 Year Return
Current Value
$163.751 Year Return
Market Cap
$29.57B
P/E Ratio
22.37
1Y Stock Return
-29.70%
1Y Revenue Growth
2.95%
Dividend Yield
0.00%
Price to Book
4.9
Double maintains 9 strategies that include IQV - IQVIA Holdings, Inc.
Medium risk
$14.0K
The textbook passive investment vehicle is generally considered to comprise of 500 of the largest stocks traded within the US. Double's take on this exposes a client to the US stock market in a diversified way without any expense ratio.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
Medium risk
$6.8K
This Strategy targets undervalued stocks in the U.S. market, emphasizing companies with solid fundamentals and potential for long-term growth. Emphasizing sectors such as healthcare, financials, industrials, and consumer goods, it seeks opportunities where market prices may not fully reflect underlying value metrics like earnings and book value.
Top Sector
Financials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
337
Medium risk
$3.8K
Targeting mid-sized U.S. companies, striking a balance between growth potential and stability. Investing in sectors like industrials, technology, consumer goods, and healthcare, it offers exposure to companies with established market positions and growth opportunities.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
316
Medium risk
$14.0K
This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
346
Medium risk
$3.1K
This index provides equal-weight exposure to the top 500 companies in the US, offering a unique approach compared to traditional market-cap weighted indexes. With an aim to reduce concentration risk by allocating equal amounts to each constituent, it potentially benefits from smaller companies' outperformance.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
Medium risk
$33.0K
This strategy tracks a market-cap-weighted index of the 1000-largest US companies. It offers broad exposure to the US equity market, encompassing a diverse range of sectors and industries. By investing in this fund, you gain access to the performance of large and well-established companies within the US economy.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
1000
The stocks that are correlated to IQV - IQVIA Holdings, Inc. are CRL, ICLR, MEDP, A, TMO
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
71.11% | $7.21B | -43.76% | 0.00% | |
I ICLRICON plc | 63.66% | $13.21B | -47.76% | 0.00% |
58.11% | $9.27B | -21.86% | 0.00% | |
57.79% | $31.27B | -22.41% | 0.92% | |
57.41% | $177.32B | -17.63% | 0.35% | |
B BRKRBruker Corp. | 57.15% | $5.71B | -58.05% | 0.56% |
R RVTYRevvity, Inc. | 55.51% | $12.10B | -0.91% | 0.29% |
T TECHBio-Techne Corp. | 55.22% | $8.67B | -18.18% | 0.61% |
52.22% | $22.83B | -14.74% | 0.00% | |
T TXTTextron, Inc. | 51.72% | $12.14B | -29.98% | 0.13% |
A AZTAAzenta, Inc. | 50.79% | $1.43B | -46.19% | 0.00% |
50.10% | $31.11B | -12.79% | 0.00% | |
W WATWaters Corp. | 49.70% | $20.50B | +3.25% | 0.00% |
48.26% | $22.29B | -7.59% | 2.55% | |
A AVTRAvantor, Inc. | 47.93% | $10.67B | -37.57% | 0.00% |
C CARRCarrier Global Corp. | 47.48% | $52.46B | +8.72% | 1.37% |
46.94% | $6.58B | -27.28% | 0.00% | |
46.91% | $3.90B | +0.91% | 0.00% | |
46.81% | $612.46M | -82.15% | 0.00% | |
S SDGRSchrödinger, Inc. | 46.81% | $1.38B | -27.56% | 0.00% |
The ETFs that are correlated to IQV - IQVIA Holdings, Inc. are RSPH, BBH, IBB, FXH, FHLC
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
63.64% | $790.48M | 0.4% | |
62.52% | $362.92M | 0.35% | |
62.19% | $5.70B | 0.45% | |
61.57% | $964.24M | 0.62% | |
60.60% | $2.68B | 0.084% | |
60.46% | $16.30B | 0.09% | |
58.70% | $294.73M | 0% | |
58.23% | $3.17B | 0.39% | |
57.87% | $13.48B | 0.47% | |
57.16% | $229.13M | 0.58% | |
56.50% | $422.06M | 0.49% | |
55.99% | $1.49B | 0.3% | |
55.80% | $1.89B | 0.39% | |
55.68% | $37.96B | 0.09% | |
55.61% | $1.09B | 0.56% | |
55.60% | $3.91B | 0.41% | |
55.09% | $73.74B | 0.2% | |
54.69% | $48.48M | 0.5% | |
54.54% | $1.20B | 0.09% | |
54.50% | $600.30M | 0.15% |
MarketWatch
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors
Yahoo
It hasn't been the best quarter for IQVIA Holdings Inc. ( NYSE:IQV ) shareholders, since the share price has fallen 11...
MarketWatch
IQVIA Holdings Inc. stock outperforms competitors on strong trading day
MarketWatch
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors
SeekingAlpha
Impax Global Social Leaders Fund underperformed the benchmark during the quarter. Positive performance came from Industrials. Read more here.
SeekingAlpha
Impax Large Cap Fundâs equities posted marginally positive returns during a fourth quarter that was dominated by the US presidential elections and its ramifications.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds